ODI Pharma Balance Sheet Health
Financial Health criteria checks 6/6
ODI Pharma has a total shareholder equity of SEK2.0M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK7.3M and SEK5.3M respectively.
Key information
0%
Debt to equity ratio
kr0
Debt
Interest coverage ratio | n/a |
Cash | kr6.52m |
Equity | kr2.04m |
Total liabilities | kr5.31m |
Total assets | kr7.35m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ODI's short term assets (SEK7.3M) exceed its short term liabilities (SEK5.3M).
Long Term Liabilities: ODI has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: ODI is debt free.
Reducing Debt: ODI has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ODI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ODI has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 6.2% each year.